Archives for May 29, 2007

← 2007

MDS Pharma ends FDA probe nightmare

By  Emilie Reymond

MDS Pharma has decided to continue the 'consolidation' of its Canadian operations by putting an end to some activities at its Montreal facility, cutting 160 jobs.

Merck in two-year 'natural product' deal

By  Emilie Reymond

German drug maker Merck KGaA is pursuing its natural products-derived drug strategy through a new deal signed with drug discovery firm AnalytiCon.

Ethical reputations of top pharma firms revealed

By  Kirsty Barnes

The latest ethical reputations of the world's largest pharmaceutical companies have been revealed, with GlaxoSmithKline (GSK) emerging as big pharma's Mother Theresa, according to a recently-released compilation by Geneva-based ethical-monitoring...

Drugging the 'undruggable'

By  Mike Nagle

Over 50 per cent of proteins in the body are considered too difficult to target with drugs; they are 'undruggable'. Yet it is exactly these molecules US pharma firm Avalon is focussing on.

Vivalis tech fuelling flu vaccine development

By  Anna Lewcock

Biopharma firm Vivalis has announced several licence agreements for its proprietary cell line technology, adding to the list of companies applying the technology to develop and commercialise new human influenza vaccines.

ISO invigorates packaging standards

By  Anna Lewcock

Alcan Packaging Kreuzlingen is the latest company to receive certification for the new ISO standard for primary packaging, becoming the first flexible packaging firm in the world to achieve the accreditation.